Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Nicotinamide Phosphoribosyltransferase Market Growth 2022-2028

  • LP 4793495
  • 91 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Nicotinamide Phosphoribosyltransferase will have significant change from previous year. According to our (LP Information) latest study, the global Nicotinamide Phosphoribosyltransferase market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Nicotinamide Phosphoribosyltransferase market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Nicotinamide Phosphoribosyltransferase market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nicotinamide Phosphoribosyltransferase market, reaching US$ million by the year 2028. As for the Europe Nicotinamide Phosphoribosyltransferase landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Nicotinamide Phosphoribosyltransferase players cover Genentech, Inc., Angelini Group, Calico LLC, and FORMA Therapeutics, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Nicotinamide Phosphoribosyltransferase market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Hormone

Lipids

Small Molecule Compounds

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Parkinson's Disease

Acute Lung Injury

Breast Cancer

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Genentech, Inc.

Angelini Group

Calico LLC

FORMA Therapeutics, Inc.

OncoTartis, Inc.

Karyopharm Therapeutics, Inc.

Aurigene Discovery Technologies Limited

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nicotinamide Phosphoribosyltransferase Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Nicotinamide Phosphoribosyltransferase by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Nicotinamide Phosphoribosyltransferase by Country/Region, 2017, 2022 & 2028

2.2 Nicotinamide Phosphoribosyltransferase Segment by Type

2.2.1 Hormone

2.2.2 Lipids

2.2.3 Small Molecule Compounds

2.2.4 Others

2.3 Nicotinamide Phosphoribosyltransferase Sales by Type

2.3.1 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2017-2022)

2.3.2 Global Nicotinamide Phosphoribosyltransferase Revenue and Market Share by Type (2017-2022)

2.3.3 Global Nicotinamide Phosphoribosyltransferase Sale Price by Type (2017-2022)

2.4 Nicotinamide Phosphoribosyltransferase Segment by Application

2.4.1 Parkinson's Disease

2.4.2 Acute Lung Injury

2.4.3 Breast Cancer

2.4.4 Others

2.5 Nicotinamide Phosphoribosyltransferase Sales by Application

2.5.1 Global Nicotinamide Phosphoribosyltransferase Sale Market Share by Application (2017-2022)

2.5.2 Global Nicotinamide Phosphoribosyltransferase Revenue and Market Share by Application (2017-2022)

2.5.3 Global Nicotinamide Phosphoribosyltransferase Sale Price by Application (2017-2022)

3 Global Nicotinamide Phosphoribosyltransferase by Company

3.1 Global Nicotinamide Phosphoribosyltransferase Breakdown Data by Company

3.1.1 Global Nicotinamide Phosphoribosyltransferase Annual Sales by Company (2020-2022)

3.1.2 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Company (2020-2022)

3.2 Global Nicotinamide Phosphoribosyltransferase Annual Revenue by Company (2020-2022)

3.2.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Company (2020-2022)

3.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Company (2020-2022)

3.3 Global Nicotinamide Phosphoribosyltransferase Sale Price by Company

3.4 Key Manufacturers Nicotinamide Phosphoribosyltransferase Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Nicotinamide Phosphoribosyltransferase Product Location Distribution

3.4.2 Players Nicotinamide Phosphoribosyltransferase Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Nicotinamide Phosphoribosyltransferase by Geographic Region

4.1 World Historic Nicotinamide Phosphoribosyltransferase Market Size by Geographic Region (2017-2022)

4.1.1 Global Nicotinamide Phosphoribosyltransferase Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Nicotinamide Phosphoribosyltransferase Annual Revenue by Geographic Region

4.2 World Historic Nicotinamide Phosphoribosyltransferase Market Size by Country/Region (2017-2022)

4.2.1 Global Nicotinamide Phosphoribosyltransferase Annual Sales by Country/Region (2017-2022)

4.2.2 Global Nicotinamide Phosphoribosyltransferase Annual Revenue by Country/Region

4.3 Americas Nicotinamide Phosphoribosyltransferase Sales Growth

4.4 APAC Nicotinamide Phosphoribosyltransferase Sales Growth

4.5 Europe Nicotinamide Phosphoribosyltransferase Sales Growth

4.6 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Growth

5 Americas

5.1 Americas Nicotinamide Phosphoribosyltransferase Sales by Country

5.1.1 Americas Nicotinamide Phosphoribosyltransferase Sales by Country (2017-2022)

5.1.2 Americas Nicotinamide Phosphoribosyltransferase Revenue by Country (2017-2022)

5.2 Americas Nicotinamide Phosphoribosyltransferase Sales by Type

5.3 Americas Nicotinamide Phosphoribosyltransferase Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nicotinamide Phosphoribosyltransferase Sales by Region

6.1.1 APAC Nicotinamide Phosphoribosyltransferase Sales by Region (2017-2022)

6.1.2 APAC Nicotinamide Phosphoribosyltransferase Revenue by Region (2017-2022)

6.2 APAC Nicotinamide Phosphoribosyltransferase Sales by Type

6.3 APAC Nicotinamide Phosphoribosyltransferase Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Nicotinamide Phosphoribosyltransferase by Country

7.1.1 Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2017-2022)

7.1.2 Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2017-2022)

7.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Type

7.3 Europe Nicotinamide Phosphoribosyltransferase Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nicotinamide Phosphoribosyltransferase by Country

8.1.1 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2017-2022)

8.1.2 Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2017-2022)

8.2 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Type

8.3 Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Nicotinamide Phosphoribosyltransferase

10.3 Manufacturing Process Analysis of Nicotinamide Phosphoribosyltransferase

10.4 Industry Chain Structure of Nicotinamide Phosphoribosyltransferase

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Nicotinamide Phosphoribosyltransferase Distributors

11.3 Nicotinamide Phosphoribosyltransferase Customer

12 World Forecast Review for Nicotinamide Phosphoribosyltransferase by Geographic Region

12.1 Global Nicotinamide Phosphoribosyltransferase Market Size Forecast by Region

12.1.1 Global Nicotinamide Phosphoribosyltransferase Forecast by Region (2023-2028)

12.1.2 Global Nicotinamide Phosphoribosyltransferase Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Nicotinamide Phosphoribosyltransferase Forecast by Type

12.7 Global Nicotinamide Phosphoribosyltransferase Forecast by Application

13 Key Players Analysis

13.1 Genentech, Inc.

13.1.1 Genentech, Inc. Company Information

13.1.2 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Offered

13.1.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Genentech, Inc. Main Business Overview

13.1.5 Genentech, Inc. Latest Developments

13.2 Angelini Group

13.2.1 Angelini Group Company Information

13.2.2 Angelini Group Nicotinamide Phosphoribosyltransferase Product Offered

13.2.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Angelini Group Main Business Overview

13.2.5 Angelini Group Latest Developments

13.3 Calico LLC

13.3.1 Calico LLC Company Information

13.3.2 Calico LLC Nicotinamide Phosphoribosyltransferase Product Offered

13.3.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Calico LLC Main Business Overview

13.3.5 Calico LLC Latest Developments

13.4 FORMA Therapeutics, Inc.

13.4.1 FORMA Therapeutics, Inc. Company Information

13.4.2 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Offered

13.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 FORMA Therapeutics, Inc. Main Business Overview

13.4.5 FORMA Therapeutics, Inc. Latest Developments

13.5 OncoTartis, Inc.

13.5.1 OncoTartis, Inc. Company Information

13.5.2 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Offered

13.5.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 OncoTartis, Inc. Main Business Overview

13.5.5 OncoTartis, Inc. Latest Developments

13.6 Karyopharm Therapeutics, Inc.

13.6.1 Karyopharm Therapeutics, Inc. Company Information

13.6.2 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Offered

13.6.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Karyopharm Therapeutics, Inc. Main Business Overview

13.6.5 Karyopharm Therapeutics, Inc. Latest Developments

13.7 Aurigene Discovery Technologies Limited

13.7.1 Aurigene Discovery Technologies Limited Company Information

13.7.2 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Offered

13.7.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Aurigene Discovery Technologies Limited Main Business Overview

13.7.5 Aurigene Discovery Technologies Limited Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Nicotinamide Phosphoribosyltransferase Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Nicotinamide Phosphoribosyltransferase Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Hormone

Table 4. Major Players of Lipids

Table 5. Major Players of Small Molecule Compounds

Table 6. Major Players of Others

Table 7. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2017-2022) & (K MT)

Table 8. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2017-2022)

Table 9. Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2017-2022) & ($ million)

Table 10. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2017-2022)

Table 11. Global Nicotinamide Phosphoribosyltransferase Sale Price by Type (2017-2022) & (USD/MT)

Table 12. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2017-2022) & (K MT)

Table 13. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2017-2022)

Table 14. Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2017-2022)

Table 15. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2017-2022)

Table 16. Global Nicotinamide Phosphoribosyltransferase Sale Price by Application (2017-2022) & (USD/MT)

Table 17. Global Nicotinamide Phosphoribosyltransferase Sales by Company (2020-2022) & (K MT)

Table 18. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Company (2020-2022)

Table 19. Global Nicotinamide Phosphoribosyltransferase Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Company (2020-2022)

Table 21. Global Nicotinamide Phosphoribosyltransferase Sale Price by Company (2020-2022) & (USD/MT)

Table 22. Key Manufacturers Nicotinamide Phosphoribosyltransferase Producing Area Distribution and Sales Area

Table 23. Players Nicotinamide Phosphoribosyltransferase Products Offered

Table 24. Nicotinamide Phosphoribosyltransferase Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Nicotinamide Phosphoribosyltransferase Sales by Geographic Region (2017-2022) & (K MT)

Table 28. Global Nicotinamide Phosphoribosyltransferase Sales Market Share Geographic Region (2017-2022)

Table 29. Global Nicotinamide Phosphoribosyltransferase Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Nicotinamide Phosphoribosyltransferase Sales by Country/Region (2017-2022) & (K MT)

Table 32. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Country/Region (2017-2022)

Table 33. Global Nicotinamide Phosphoribosyltransferase Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Nicotinamide Phosphoribosyltransferase Sales by Country (2017-2022) & (K MT)

Table 36. Americas Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2017-2022)

Table 37. Americas Nicotinamide Phosphoribosyltransferase Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2017-2022)

Table 39. Americas Nicotinamide Phosphoribosyltransferase Sales by Type (2017-2022) & (K MT)

Table 40. Americas Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2017-2022)

Table 41. Americas Nicotinamide Phosphoribosyltransferase Sales by Application (2017-2022) & (K MT)

Table 42. Americas Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2017-2022)

Table 43. APAC Nicotinamide Phosphoribosyltransferase Sales by Region (2017-2022) & (K MT)

Table 44. APAC Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2017-2022)

Table 45. APAC Nicotinamide Phosphoribosyltransferase Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2017-2022)

Table 47. APAC Nicotinamide Phosphoribosyltransferase Sales by Type (2017-2022) & (K MT)

Table 48. APAC Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2017-2022)

Table 49. APAC Nicotinamide Phosphoribosyltransferase Sales by Application (2017-2022) & (K MT)

Table 50. APAC Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2017-2022)

Table 51. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2017-2022) & (K MT)

Table 52. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2017-2022)

Table 53. Europe Nicotinamide Phosphoribosyltransferase Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2017-2022)

Table 55. Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2017-2022) & (K MT)

Table 56. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2017-2022)

Table 57. Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2017-2022) & (K MT)

Table 58. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Country (2017-2022) & (K MT)

Table 60. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Type (2017-2022) & (K MT)

Table 64. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales by Application (2017-2022) & (K MT)

Table 66. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Nicotinamide Phosphoribosyltransferase

Table 68. Key Market Challenges & Risks of Nicotinamide Phosphoribosyltransferase

Table 69. Key Industry Trends of Nicotinamide Phosphoribosyltransferase

Table 70. Nicotinamide Phosphoribosyltransferase Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Nicotinamide Phosphoribosyltransferase Distributors List

Table 73. Nicotinamide Phosphoribosyltransferase Customer List

Table 74. Global Nicotinamide Phosphoribosyltransferase Sales Forecast by Region (2023-2028) & (K MT)

Table 75. Global Nicotinamide Phosphoribosyltransferase Sales Market Forecast by Region

Table 76. Global Nicotinamide Phosphoribosyltransferase Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2023-2028) & (K MT)

Table 79. Americas Nicotinamide Phosphoribosyltransferase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Nicotinamide Phosphoribosyltransferase Sales Forecast by Region (2023-2028) & (K MT)

Table 81. APAC Nicotinamide Phosphoribosyltransferase Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Europe Nicotinamide Phosphoribosyltransferase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Forecast by Country (2023-2028) & (K MT)

Table 85. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Nicotinamide Phosphoribosyltransferase Sales Forecast by Type (2023-2028) & (K MT)

Table 87. Global Nicotinamide Phosphoribosyltransferase Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Nicotinamide Phosphoribosyltransferase Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Nicotinamide Phosphoribosyltransferase Sales Forecast by Application (2023-2028) & (K MT)

Table 91. Global Nicotinamide Phosphoribosyltransferase Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Nicotinamide Phosphoribosyltransferase Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share Forecast by Application (2023-2028)

Table 94. Genentech, Inc. Basic Information, Nicotinamide Phosphoribosyltransferase Manufacturing Base, Sales Area and Its Competitors

Table 95. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Offered

Table 96. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 97. Genentech, Inc. Main Business

Table 98. Genentech, Inc. Latest Developments

Table 99. Angelini Group Basic Information, Nicotinamide Phosphoribosyltransferase Manufacturing Base, Sales Area and Its Competitors

Table 100. Angelini Group Nicotinamide Phosphoribosyltransferase Product Offered

Table 101. Angelini Group Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 102. Angelini Group Main Business

Table 103. Angelini Group Latest Developments

Table 104. Calico LLC Basic Information, Nicotinamide Phosphoribosyltransferase Manufacturing Base, Sales Area and Its Competitors

Table 105. Calico LLC Nicotinamide Phosphoribosyltransferase Product Offered

Table 106. Calico LLC Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 107. Calico LLC Main Business

Table 108. Calico LLC Latest Developments

Table 109. FORMA Therapeutics, Inc. Basic Information, Nicotinamide Phosphoribosyltransferase Manufacturing Base, Sales Area and Its Competitors

Table 110. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Offered

Table 111. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 112. FORMA Therapeutics, Inc. Main Business

Table 113. FORMA Therapeutics, Inc. Latest Developments

Table 114. OncoTartis, Inc. Basic Information, Nicotinamide Phosphoribosyltransferase Manufacturing Base, Sales Area and Its Competitors

Table 115. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Offered

Table 116. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 117. OncoTartis, Inc. Main Business

Table 118. OncoTartis, Inc. Latest Developments

Table 119. Karyopharm Therapeutics, Inc. Basic Information, Nicotinamide Phosphoribosyltransferase Manufacturing Base, Sales Area and Its Competitors

Table 120. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Offered

Table 121. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 122. Karyopharm Therapeutics, Inc. Main Business

Table 123. Karyopharm Therapeutics, Inc. Latest Developments

Table 124. Aurigene Discovery Technologies Limited Basic Information, Nicotinamide Phosphoribosyltransferase Manufacturing Base, Sales Area and Its Competitors

Table 125. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Offered

Table 126. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 127. Aurigene Discovery Technologies Limited Main Business

Table 128. Aurigene Discovery Technologies Limited Latest Developments

List of Figures

Figure 1. Picture of Nicotinamide Phosphoribosyltransferase

Figure 2. Nicotinamide Phosphoribosyltransferase Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nicotinamide Phosphoribosyltransferase Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Nicotinamide Phosphoribosyltransferase Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Nicotinamide Phosphoribosyltransferase Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Hormone

Figure 10. Product Picture of Lipids

Figure 11. Product Picture of Small Molecule Compounds

Figure 12. Product Picture of Others

Figure 13. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type in 2021

Figure 14. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2017-2022)

Figure 15. Nicotinamide Phosphoribosyltransferase Consumed in Parkinson's Disease

Figure 16. Global Nicotinamide Phosphoribosyltransferase Market: Parkinson's Disease (2017-2022) & (K MT)

Figure 17. Nicotinamide Phosphoribosyltransferase Consumed in Acute Lung Injury

Figure 18. Global Nicotinamide Phosphoribosyltransferase Market: Acute Lung Injury (2017-2022) & (K MT)

Figure 19. Nicotinamide Phosphoribosyltransferase Consumed in Breast Cancer

Figure 20. Global Nicotinamide Phosphoribosyltransferase Market: Breast Cancer (2017-2022) & (K MT)

Figure 21. Nicotinamide Phosphoribosyltransferase Consumed in Others

Figure 22. Global Nicotinamide Phosphoribosyltransferase Market: Others (2017-2022) & (K MT)

Figure 23. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2017-2022)

Figure 24. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application in 2021

Figure 25. Nicotinamide Phosphoribosyltransferase Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Company in 2021

Figure 27. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Geographic Region in 2021

Figure 29. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2017-2022)

Figure 30. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country/Region in 2021

Figure 31. Americas Nicotinamide Phosphoribosyltransferase Sales 2017-2022 (K MT)

Figure 32. Americas Nicotinamide Phosphoribosyltransferase Revenue 2017-2022 ($ Millions)

Figure 33. APAC Nicotinamide Phosphoribosyltransferase Sales 2017-2022 (K MT)

Figure 34. APAC Nicotinamide Phosphoribosyltransferase Revenue 2017-2022 ($ Millions)

Figure 35. Europe Nicotinamide Phosphoribosyltransferase Sales 2017-2022 (K MT)

Figure 36. Europe Nicotinamide Phosphoribosyltransferase Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales 2017-2022 (K MT)

Figure 38. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue 2017-2022 ($ Millions)

Figure 39. Americas Nicotinamide Phosphoribosyltransferase Sales Market Share by Country in 2021

Figure 40. Americas Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country in 2021

Figure 41. United States Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Nicotinamide Phosphoribosyltransferase Sales Market Share by Region in 2021

Figure 46. APAC Nicotinamide Phosphoribosyltransferase Revenue Market Share by Regions in 2021

Figure 47. China Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Nicotinamide Phosphoribosyltransferase Sales Market Share by Country in 2021

Figure 54. Europe Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country in 2021

Figure 55. Germany Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Nicotinamide Phosphoribosyltransferase Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Nicotinamide Phosphoribosyltransferase Revenue Market Share by Country in 2021

Figure 62. Egypt Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Nicotinamide Phosphoribosyltransferase Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Nicotinamide Phosphoribosyltransferase in 2021

Figure 68. Manufacturing Process Analysis of Nicotinamide Phosphoribosyltransferase

Figure 69. Industry Chain Structure of Nicotinamide Phosphoribosyltransferase

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390